Antioxidative enzyme activities and lipid peroxidation in major depression: Alterations by antidepressant treatments

Journal of Affective Disorders

Volumn 64, Issue 1, 2001, Pages 43-51

  Bilici, Mustafa ^a   Efe, Hasan ^a   Köroğlu, M Arif ^a   Uydu, Hüseyin Avni ^a   Bekaroglu M ^a   Deger O ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Antidepressants; Antioxidants; Free radicals; Major Depression

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIOXIDANT; CATALASE; CITALOPRAM; FLUOXETINE; FLUVOXAMINE; FREE RADICAL; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; LIPID PEROXIDASE; MALONALDEHYDE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SUPEROXIDE DISMUTASE;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DRUG EFFECT; DRUG MONITORING; ENZYME ACTIVITY; ERYTHROCYTE LEVEL; FEMALE; HUMAN; HUMAN CELL; LIPID PEROXIDATION; LONG TERM CARE; MALE; MELANCHOLIA; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; TREATMENT OUTCOME;

ADULT; AGE FACTORS; ANTIDEPRESSIVE AGENTS; CATALASE; CHOLESTEROL; DEPRESSIVE DISORDER, MAJOR; ERYTHROCYTE COUNT; FEMALE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HUMANS; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; REACTIVE OXYGEN SPECIES; TRIGLYCERIDES;

EID: 0035065919     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(00)00199-3     Document Type: Article

References (47)

1. Depression and long-term mortality risk in patients with coronary artery disease
2. Effect of antidepressant treatment on acute phase protein levels in patients with depression
3. Influence of brodimoprim on polymorphonuclear leukocyte phagocytosis and oxidant radical production
4. Elimination of ascorbic acid-induced membrane lipid peroxidation and serotonin receptor loss by Trolox-C., a water soluble analogue of vitamin E
5. Oxidative stress, the paradox of aerobic life
6. Polymorphonuclear (PMN) elastase levels in depressive disorders
7. Decreased neutrophil antioxidative enzyme activities and increased lipid peroxidation in hyperlipoproteinemic human subjects
8. Messengers and mediators, interactions among lipids eicosanoids and cytokines
9. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes
10. Free radicals in brain metabolism and pathology
11. Mechanisms of cell injury by activated oxygen species
12. Psychiatry, psychopharmacology and P450s
13. Free radicals in disease processes, a compilation of cause and consequence
14. Lipid peroxidation and antioxidants as biomarkers of tissue damage
15. The assessment of anxiety states by rating
16. A rating scale for depression
17. Essential fatty acids, psychiatric disorders and neuropathies
18. Characterization of the potential antioxidant and pro-oxidant actions of some neuroleptic drugs
19. Depression and immunity, the biochemical interrelationship between the central nervous system and the immune system
20. Arteriosclerotic depression
21. Lipids
22. The serotonin hypothesis of major depression
23. Evidence for a systemic immune activation during depression, results of leukocyte enumeration by flow cytometry in conjunction with monoclonal antibody staining
24. Increased plasma concentrations of interleukin-6., soluble interleukin-6., soluble interleukin-2 and transferrin receptor in major depression
25. Fatty acid composition in major depression, decreased ω3 fractions in cholesteryl esters and increased C20, 4ω6/C20, 5ω3 ratio in cholesteryl esters and phospholipids
26. Immune disturbances in treatment-resistant depression, modulation by antidepressive treatments
27. The role of monoamine metabolism in oxidative glutamate toxicity
28. Depression in patients with cancer. Diagnosis, biology, and treatment
29. Familial LCAT deficiency and fish-eye disease
30. Psychoneuroimmunology, implications for the drug treatment of psychiatric disorders
31. Monoamine oxidase and cortisol response in depression and schizophrenia
32. Determinants of antioxidant status in humans
33. Lymphocyte subsets associated with major depression and dysthymia, modification by antidepressant treatment
34. On the functions of monoamine oxidase, the emotions, and adaptation to stress
35. Increased CD56+ natural killer cells and related cytokines in major depression
36. Suppression of interleukin-1 action by phospholipase-A2 inhibitors in helper T lymphocytes
37. Indicators of immune activation in major depression
38. Effect of dietary salt and cholesterol loading on vascular adrenergic receptors
39. Effect of oxidative stress on receptors and signal transmission
40. Automated assay for superoxide dismutase, catalase, glutathione peroxidase, and glutathione reductase activity
41. A detailed analysis of hydrogen peroxide-induced cell death in primary neuronal culture
42. Lipid peroxides and related radicals in clinical medicine
43. Hamilton Anxiety Rating Scale, Interrater reliability and validity study
44. Phenothiazines as lipid peroxidation inhibitors and cytoprotective agents
45. Receiver operating characteristics (ROC) plots, a fundamental evaluation tool in clinical medicine